Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Treatment |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme |
|
Kingsport, TN USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Memphis, TN USA |
|
03/01/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Nashville, TN USA |
|
03/01/2008 |
|
|
|
|
|
Details |
|
A Phase I/II Trial of Maximal Resection, Local Radiation Boost With Concomitant Temozolomide, Followed by External Radiation Therapy With Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme |
|
Memphis, TN USA |
|
12/11/2007 |
|
|
|
Details |
|
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma |
|
Nashville, TN USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Kingsport, TN USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Knoxville, TN USA |
|
04/29/2007 |
|
|
|
|
|
Details |
|
Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas |
|
Memphis, TN USA |
|
04/29/2007 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Knoxville, TN USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Johnson City, TN USA |
|
10/12/2006 |
|
|
|
Details |
|
Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) |
|
Nashville, TN USA |
|
10/12/2006 |
|
|
|
|
|
Details |
|
Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma |
|
Nashville, TN USA |
|
05/30/2006 |
|
|
|
Details |
|
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors |
|
Memphis, TN USA |
|
05/27/2006 |
|
|
|
|
|
Details |
|
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
|
Memphis, TN USA |
|
05/02/2006 |
|
|
|
Details |
|
Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors |
|
Memphis, TN USA |
|
05/01/2006 |
|
|
|
|
|
Details |
|
ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors |
|
Memphis, TN USA |
|
12/03/2005 |
|
|
|
Details |
|
Treatment of newly diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor (PNET), or Atypical Teratoid Rhabdoid Tumor (ATRT) |
|
Memphis, TN USA |
|
12/03/2005 |
|
|
|
|
|
Details |
|
Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants with Brain Tumors |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Knoxville, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Johnson City, TN USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Nashville, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
|
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
|
|
Details |
|
Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma |
|
Memphis, TN USA |
|
11/27/2005 |
|
|
|
Details |
|
PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma |
|
Nashville, TN USA |
|
11/26/2005 |
|
|
|
|
|
Details |
|
Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
|
|
Memphis, TN USA |
|
11/26/2005 |
|
|
|
Details |
|
A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection
|
|
Memphis, TN USA |
|
11/13/2005 |
|
|
|
|
|
Details |
|
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma(or Glioblastoma multiforme) |
|
Memphis, TN USA |
|
11/11/2005 |
|
|
|
Details |
|
Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
|
|
Memphis, TN USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia |
|
Memphis, TN USA |
|
11/11/2005 |
|
|
|
Details |
|
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors |
|
Memphis, TN USA |
|
11/11/2005 |
|
|
|
|
|
Details |
|
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
|
Memphis, TN USA |
|
11/11/2005 |
|
|
|
Details |
|
Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma |
|
Memphis, TN USA |
|
11/06/2005 |
|
|
|
|
|
